Al Hayek Ayman A, Robert Asirvatham A, Al Dawish Mohamed A
Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Clin Med Insights Endocrinol Diabetes. 2020 Mar 16;13:1179551420910122. doi: 10.1177/1179551420910122. eCollection 2020.
In the current era of modern technology, the development of smart devices such as the flash glucose monitoring (FGM) systems helps patients with diabetes to effortlessly monitor their glucose levels more frequently. In this study, we determine the user acceptability of FGM among young patients with type 1 diabetes (T1D).
A cross-sectional study was performed among 67 young patients with T1D in the age group of 13 to 19 years and who were managed on the FGM method for self-testing the glucose levels for a minimum of 6 months. The participants acceptability measures that were collected with a standard questionnaire and where they rated their experience with the system on a scale of 1 (strongly agree/painless) to 5 (strongly disagree/severe pain). In addition to the demographic and clinical parameters, a closed/structured questionnaire was administered, in order to record the prior and present skin issues, over a 6-month period.
From the patient statements regarding sensor application, 95.5% of the study population strongly agreed that the sensor application caused less pain than the routine finger-stick. Similarly, 85% of the users strongly agreed that using the sensor was comfortable, while 94% strongly agreed that they found the small size of the FGM made it easy to wear, 47.8% strongly agreed that wearing the sensor did not attract attention, 70.1% reported no discomfort under the skin, 80.6% stated that the sensor could be scanned without anyone noticing it, 89.6% felt that the sensor did not affect their daily activities, 91% strongly agreed that the sensor was very compatible with their lifestyle, 79.1% reported ease with taking a glucose reading with the scan, 89.6% reported that taking glucose readings with this system would not disrupt their daily activities, and 76.1% participants were excited to share with other individuals their experiences with this system. A comparison of the self-monitoring of blood glucose and freestyle techniques demonstrated that 83.6% participants strongly agreed that it was less painful to get glucose readings from the freestyle sensor, and that it was a more discreet (83.6%), more comfortable (85.1%), easier (95.5%), faster (82.1%), simpler (79.1%), more private (88.1%), and less stressful (77.6%) method, with minimal hassle (74.6%). It is notable here that 86.6% of the participants reported absolutely no pain when the freestyle sensor was applied; also, the majority of the participants (91%) reported no pain symptoms when scanning the sensor.
The findings of this study clearly showed that the study population had a high level of acceptability of the FGM.
在现代科技的当下，诸如闪光葡萄糖监测（FGM）系统等智能设备的发展有助于糖尿病患者更轻松地更频繁地监测血糖水平。在本研究中，我们确定了FGM在1型糖尿病（T1D）年轻患者中的用户可接受性。
对67名年龄在13至19岁之间、采用FGM方法自我检测血糖水平至少6个月的T1D年轻患者进行了一项横断面研究。通过标准问卷收集参与者的可接受性指标，他们对该系统体验的评分范围为1（强烈同意/无痛）至5（强烈不同意/剧痛）。除了人口统计学和临床参数外，还发放了一份封闭式/结构化问卷，以记录6个月期间既往和当前的皮肤问题。
从患者关于传感器应用的陈述来看，95.5%的研究人群强烈同意传感器应用比常规指尖采血引起的疼痛更少。同样，85%的用户强烈同意使用传感器很舒适，94%的用户强烈同意他们发现FGM体积小便于佩戴，47.8%的用户强烈同意佩戴传感器不会引人注意，70.1%的用户报告皮肤下无不适，80.6%的用户表示传感器扫描时不会被人注意到，89.6%的用户认为传感器不影响他们的日常活动，91%的用户强烈同意传感器与他们的生活方式非常契合，79.1%的用户报告扫描获取血糖读数很容易，89.6%的用户报告使用该系统获取血糖读数不会干扰他们的日常活动，76.1%的参与者很乐意与其他人分享他们使用该系统的经历。血糖自我监测与自由式技术的比较表明，83.6%的参与者强烈同意从自由式传感器获取血糖读数疼痛更少，且该方法更隐蔽（83.6%）、更舒适（85.1%）、更简便（95.5%）、更快（82.1%）、更简单（79.1%）、更私密（88.1%）、压力更小（77.6%），麻烦最少（74.6%）。值得注意的是，86.6%的参与者报告应用自由式传感器时完全没有疼痛；此外大部分参与者（91%）报告扫描传感器时没有疼痛症状。
本研究结果清楚地表明，研究人群对FGM具有高度的可接受性。
